The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Intraventricular HemorrhageSubarachnoid Hemorrhage
Interventions
DEVICE

CerebroFlo™ EVD Catheter

The CerebroFlo™ EVD Catheter is indicated for temporary insertion into a ventricular cavity of the brain for external drainage of cerebrospinal fluid (CSF) in those patients with elevated intracranial pressure (ICP), intraventricular hemorrhage, or hydrocephalic shunt infections.

Trial Locations (10)

10029

Icahn School of Medicine at Mt. Sinai, New York

23298

Virginia Commonwealth University Department of Neurosurgery, Richmond

32803

AdventHealth Orlando, Orlando

45409

Wright State University/Premier Health, Dayton

70808

Our Lady of the Lake Regional Medical Center, Baton Rouge

78229

University of Texas Health Science Center, San Antonio

80045

University of Colorado Anschutz Medical Campus, Aurora

84123

University of Utah Health, Salt Lake City

92350

Loma Linda University Health, Loma Linda

94304

Stanford University, Palo Alto

All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT05113381 - The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH) | Biotech Hunter | Biotech Hunter